Patient characteristics
Parameters . | N . | n . | % . |
---|---|---|---|
Age ≥60 y | 282 | 177 | 63 |
Age ≥70 y | 282 | 107 | 38 |
Male sex | 282 | 170 | 60 |
Stage III-IV | 282 | 254 | 90 |
ECOG performance status >2 | 262 | 80 | 31 |
B symptoms | 268 | 172 | 64 |
Bulky disease >5 cm | 282 | 30 | 11 |
Extranodal sites ≥2 | 268 | 88 | 33 |
Bone marrow involvement | 268 | 36 | 13 |
LDH > ULN | 240 | 139 | 58 |
Hemoglobin <12 g/dL | 261 | 158 | 61 |
Platelets <150 000/mm3 | 262 | 73 | 28 |
Monocytes <800/mm3 | 237 | 179 | 76 |
ANC >6500/mm3 | 251 | 88 | 35 |
β2M > ULN | 125 | 99 | 79 |
CRP > ULN | 151 | 108 | 82 |
IPI ≥3 | 183 | 102 | 56 |
PIT ≥2 | 183 | 113 | 62 |
PIAI ≥2 | 183 | 115 | 63 |
Parameters . | N . | n . | % . |
---|---|---|---|
Age ≥60 y | 282 | 177 | 63 |
Age ≥70 y | 282 | 107 | 38 |
Male sex | 282 | 170 | 60 |
Stage III-IV | 282 | 254 | 90 |
ECOG performance status >2 | 262 | 80 | 31 |
B symptoms | 268 | 172 | 64 |
Bulky disease >5 cm | 282 | 30 | 11 |
Extranodal sites ≥2 | 268 | 88 | 33 |
Bone marrow involvement | 268 | 36 | 13 |
LDH > ULN | 240 | 139 | 58 |
Hemoglobin <12 g/dL | 261 | 158 | 61 |
Platelets <150 000/mm3 | 262 | 73 | 28 |
Monocytes <800/mm3 | 237 | 179 | 76 |
ANC >6500/mm3 | 251 | 88 | 35 |
β2M > ULN | 125 | 99 | 79 |
CRP > ULN | 151 | 108 | 82 |
IPI ≥3 | 183 | 102 | 56 |
PIT ≥2 | 183 | 113 | 62 |
PIAI ≥2 | 183 | 115 | 63 |
ANC, absolute neutrophil count; CRP, C-reactive protein; ULN, upper limit of normal.